BioNTech-Pfizer raise 2021 Covid-19 vaccine output goal to 2.5 bn doses

BioNTech and Pfizer will boost manufacturing capacity of their COVID-19 vaccine to 2.5 billion doses by the end of 2021, BioNTech said on Tuesday, as it projected sales of nearly 10 billion euros ($11.7 billion) from the product this year.
 

Pfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021.
 

BioNTech cited its new facility in the German city of Marburg and an expansion of the pair's network of third-party manufacturers and suppliers as drivers of the larger volumes.
 

"Additional measures and discussions with potential partners to further expand the manufacturing capacity and